AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30

Authors: Chesney, RW
Citation: Rw. Chesney, The impact of medical school loans and the promise of loan repayment on entry into a pediatric academic career, ARCH PED AD, 155(12), 2001, pp. 1296-1297

Authors: Maung, HM Elangovan, L Frazao, JM Bower, JD Kelley, BJ Acchiardo, SR Rodriguez, HJ Norris, KC Sigala, JF Rutkowski, M Robertson, JA Goodman, WG Levine, BS Chesney, RW Mazess, RB Kyllo, DM Douglass, LL Bishop, CW Coburn, JW
Citation: Hm. Maung et al., Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison, AM J KIDNEY, 37(3), 2001, pp. 532-543

Authors: Chesney, RW
Citation: Rw. Chesney, Joseph W. St. Geme, Jr address 2001: Can one have a successful academic career in 2001?, PEDIATRICS, 108(6), 2001, pp. 1349-1352

Authors: Chesney, RW Simon, J Alden, E Gruskin, A Williams, R
Citation: Rw. Chesney et al., The FOPE II commentary, PEDIATRICS, 108(6), 2001, pp. 1392-1393

Authors: Chesney, RW
Citation: Rw. Chesney, Privacy and its regulation: Too much too soon, or too little too late, PEDIATRICS, 107(6), 2001, pp. 1423-1425

Authors: Chesney, RW Dungy, CI Gillman, MW Rivara, FP Schonfeld, DJ Takayama, JI
Citation: Rw. Chesney et al., Promoting education, mentorship, and support for pediatric research, PEDIATRICS, 107(6), 2001, pp. 1447-1450

Authors: Chesney, RW Adamson, P Wells, T Wilson, JT Walson, PD
Citation: Rw. Chesney et al., The testing of antihypertensive medications in children: Report of the antihypertensive agent guidelines subcommittee of the Pediatric Pharmacology Research Units, PEDIATRICS, 107(3), 2001, pp. 558-561

Authors: Chesney, RW McAnarney, E
Citation: Rw. Chesney et E. Mcanarney, AMSPDC: An overview of its history and evolving mission, J PEDIAT, 138(5), 2001, pp. 615-616

Authors: Chesney, RW
Citation: Rw. Chesney, A practical approach to the evaluation of antihypertensive agents in infants and children: Study design and outcome measures, CURR THER R, 62(4), 2001, pp. 351-360

Authors: Blumer, JL Flynn, JT Vogt, BA Wells, T Blowey, DL Chesney, RW
Citation: Jl. Blumer et al., Labeling antihypertensive agents for children - Panel discussion, CURR THER R, 62(4), 2001, pp. 361-370

Authors: Han, X Budreau, AM Chesney, RW
Citation: X. Han et al., The taurine transporter gene and its role in renal development, AMINO ACIDS, 19(3-4), 2000, pp. 499-507

Authors: Chesney, RW Broyer, M
Citation: Rw. Chesney et M. Broyer, Untitled, PED NEPHROL, 15(3-4), 2000, pp. 331-331

Authors: Kaplan, BS Garcia, CD Chesney, RW Segar, WE Giugno, K Chem, R
Citation: Bs. Kaplan et al., Peripheral gangrene complicating idiopathic and recessive hemolytic uremicsyndromes, PED NEPHROL, 14(10-11), 2000, pp. 985-989

Authors: Frazao, JM Elangovan, L Maung, HM Chesney, RW Acchiardo, SR Bower, JD Kelley, BJ Rodriguez, HJ Norris, KC Robertson, JA Levine, BS Goodman, WG Gentile, D Mazess, RB Kyllo, DM Douglass, LL Bishop, CW Coburn, JW
Citation: Jm. Frazao et al., Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism, AM J KIDNEY, 36(3), 2000, pp. 550-561

Authors: Mulvey, HJ Alden, ER Simon, JL Chesney, RW
Citation: Hj. Mulvey et al., Untitled - Introduction, PEDIATRICS, 106(5), 2000, pp. NIL_1-NIL_2

Authors: Johnson, RL Charney, E Cheng, TL Kittredge, D Nazarian, LF Mulvey, HJ Alden, ER Simon, JL Chesney, RW
Citation: Rl. Johnson et al., Final report of the FOPE II Education of the Pediatrician Workgroup, PEDIATRICS, 106(5), 2000, pp. 1175-1198

Authors: Leslie, L Rappo, P Abelson, H Jenkins, RR Sewall, SR Mulvey, HJ Alden, ER Simon, JL Chesney, RW
Citation: L. Leslie et al., Final report of the FOPE II Pediatric Generalists of the Future Workgroup, PEDIATRICS, 106(5), 2000, pp. 1199-1223

Authors: Gruskin, A Williams, RG McCabe, ERB Stein, F Strickler, J Mulvey, HJ Alden, ER Simon, JL Chesney, RW
Citation: A. Gruskin et al., Final report of the FOPE II Pediatric Subspecialists of the Future Workgroup, PEDIATRICS, 106(5), 2000, pp. 1224-1244

Authors: DeAngelis, C Feigin, R DeWitt, T First, LR Jewett, EA Kelch, R Mulvey, HJ Alden, ER Simon, JL Chesney, RW
Citation: C. Deangelis et al., Final report of the FOPE II Pediatric Workforce Workgroup, PEDIATRICS, 106(5), 2000, pp. 1245-1255

Authors: Jones, MD Boat, T Adler, R Gephart, HR Osborn, LM Mulvey, HJ Alden, ER Simon, JL Chesney, RW
Citation: Md. Jones et al., Final report of the FOPE II Financing of Pediatric Education Workgroup, PEDIATRICS, 106(5), 2000, pp. 1256-1269

Authors: Han, XB Budreau, AM Chesney, RW
Citation: Xb. Han et al., Ser-322 is a critical site for PKC regulation of the MDCK cell taurine transporter (pNCT), J AM S NEPH, 10(9), 1999, pp. 1874-1879

Authors: Chesney, RW Broyer, M
Citation: Rw. Chesney et M. Broyer, Urolithiasis in Tunisian children: a study of 120 cases based on stone composition - Commentary, PED NEPHROL, 13(9), 1999, pp. 926-926

Authors: Chesney, RW Broyer, M
Citation: Rw. Chesney et M. Broyer, Untitled, PED NEPHROL, 13(9), 1999, pp. 1003-1003

Authors: Kaste, SC Chesney, RW Hudson, MM Lustig, RH Rose, SR Carbone, LD
Citation: Sc. Kaste et al., Bone mineral status during and after therapy of childhood cancer: An increasing population with multiple risk factors for impaired bone health, J BONE MIN, 14(12), 1999, pp. 2010-2014

Authors: Christensen, ML Helms, RA Chesney, RW
Citation: Ml. Christensen et al., Is pediatric labeling really necessary?, PEDIATRICS, 104(3), 1999, pp. 593-597
Risultati: 1-25 | 26-30